CLINICAL_TRIALS
trial_result
· 2025-07-03
Clinical Trial Update: Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism [Phase 2]
Summary
Xeris Pharmaceuticals completed a Phase 2 trial of XP-8121 for hypothyroidism and posted the results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xeris Pharmaceuticals | Conditions: Hypothyroidism | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03